FAYAGO

Serial Number 88668188
Registration 6236464
700

Registration Progress

Application Filed
Oct 24, 2019
Under Examination
Approved for Publication
Oct 20, 2020
Published for Opposition
Oct 20, 2020
Registered
Jan 5, 2021

Trademark Image

FAYAGO

Basic Information

Serial Number
88668188
Registration Number
6236464
Filing Date
October 24, 2019
Registration Date
January 5, 2021
Published for Opposition
October 20, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 5, 2021
Registration
Registered
Classes
005

Rights Holder

CStone Pharmaceuticals (Suzhou) Co. Ltd

99
Address
E168, 2nd fl, A1 North, Xinghu St. 218
Suzhou Industrial Park, Wuzhong Dist.
Suzhou 215123
CN

Ownership History

CStone Pharmaceuticals (Suzhou) Co. Ltd

Original Applicant
99
Suzhou CN

CStone Pharmaceuticals (Suzhou) Co. Ltd

Owner at Publication
99
Suzhou CN

CStone Pharmaceuticals (Suzhou) Co. Ltd

Original Registrant
99
Suzhou CN

Legal Representation

Attorney
Nan Z Carr

USPTO Deadlines

Next Deadline
523 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-01-05)
Due Date
January 05, 2027
Grace Period Ends
July 05, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Jan 5, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 20, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 20, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 30, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 14, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 10, 2020 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Sep 10, 2020 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Aug 29, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 29, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 27, 2020 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jun 24, 2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jun 24, 2020 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jun 24, 2020 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 9, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 9, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 8, 2020 ALIE A ASSIGNED TO LIE Loading...
May 29, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 30, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 29, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 30, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Medicines for human purposes, namely, medicinal preparations for cancer; cancer drugs, namely, anti-cancer preparations; anti-cancer preparations; dietetic substances adapted for medical use, namely, dietetic preparations adapted for medical purposes; radioactive substances for medical purposes; gases for medical purposes, namely, gases for medical imaging use; disinfectants; solutions for contact lenses; medicinal bacteriological research preparations for cancer; medical dressings

Classification

International Classes
005